In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol

Pharmacology, Biochemistry, and Behavior
T SumiyoshiK Yokogawa

Abstract

An in vivo receptor binding technique was applied to evaluate the affinities of risperidone and haloperidol for dopamine-D2 receptors (D2) and serotonin-5-HT2 receptors (5-HT2) in rat brain with [3H]YM-09151-2 and [3H]ketanserin as selective ligands. Radioactivities were obtained in the striatum frontal cortex, and cerebellum of the rats treated with the ligands. Time course study of receptor occupancy at 25 to 250 min after single doses of the drugs (1 mg/kg, IP) showed higher 5-HT2 occupancy in the frontal cortex and lower D2 occupancy in the striatum by risperidone than by haloperidol. Dose-response analysis of receptor occupancy revealed risperidone demonstrated higher binding affinity for 5-HT2 than for D2, while the reverse was observed with haloperidol. It appeared that risperidone (1 mg/kg, IP), but not haloperidol (1 mg/kg, IP), demonstrated regional selectivity in D2 occupancy favouring frontal cortex more than the striatum. That risperidone displayed a higher ratio of 5-HT2 to D2 in occupancy than haloperidol is in agreement with the previous findings obtained in vitro.

References

Jan 1, 1992·Clinical Neuropharmacology·S Bischoff
Jan 1, 1992·Clinical Neuropharmacology·S L Heylen, Y G Gelders
Jan 1, 1992·Clinical Neuropharmacology·S R Marder
Jan 1, 1990·Life Sciences·T SuharaK Kobayasi
Jul 29, 1985·Life Sciences·N E Goeders, M J Kuhar
Jun 16, 1982·European Journal of Pharmacology·P M LaduronJ E Leysen
Mar 1, 1993·The Japanese Journal of Psychiatry and Neurology·T SumiyoshiF Ichimura

❮ Previous
Next ❯

Citations

Mar 1, 1996·Psychopharmacology·B J Kinon, J A Lieberman
Nov 27, 2004·European Archives of Psychiatry and Clinical Neuroscience·Michael RiedelH J Möller
Sep 1, 1994·Pharmacology, Biochemistry, and Behavior·T SumiyoshiK Shiba
Jul 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·S M Allen, S N Rice
Mar 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M M MarcusT H Svensson
Feb 21, 2004·European Journal of Pharmacology·Amir H Rezvani, Edward D Levin
Mar 5, 2004·Neuropharmacology·George C WagnerAlycia K Halladay
Feb 26, 1998·Pharmacology, Biochemistry, and Behavior·S M AllenW M Davis
Apr 20, 1999·Pharmacology, Biochemistry, and Behavior·A M Montgomery, A J Grottick
Sep 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Patricia A BroderickYueping Zhou
Sep 2, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·P HertelT H Svensson
Jan 13, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·H RosengartenA J Friedhoff
May 25, 2005·Journal of Child and Adolescent Psychopharmacology·Boong-Nyun KimSoo-Churl Cho
Sep 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·P J LombrosoJ F Leckman
Nov 1, 2007·Journal of Dual Diagnosis·Ivan D Montoya, Frank Vocci
Mar 30, 2016·Pharmacogenomics·Stefano PorcelliDan Rujescu
Jun 27, 2002·Expert Opinion on Pharmacotherapy·Kirsten R Müller-Vahl
Jan 22, 2013·The International Journal of Neuropsychopharmacology·Miaojun LaiWenhua Zhou
May 10, 2001·Biological Psychiatry·T SumiyoshiH Y Meltzer
Jan 25, 2003·Journal of Clinical Psychopharmacology·Rodrigo A BressanLyn S Pilowsky
Jan 19, 2002·Journal of Clinical Psychopharmacology·Yves DionGuy Chouinard
Aug 26, 1998·Therapeutic Drug Monitoring·O V OlesenK Linnet
May 26, 2006·Journal of Medicinal Chemistry·Franck AmblardRaymond F Schinazi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.